Candida albicans isolates from a Malaysian hospital exhibit more potent phospholipase and haemolysin activities than non-albicans Candida isolates

Tropical Biomedicine

Volumn 30, Issue 4, 2013, Pages 654-662

  Chin, V K ^a   Foong, K J ^a   Maha, A ^a   Rusliza, B ^a   Norhafizah, M ^a   Ng, K P ^b   Chong, P P ^a,c  

^a UNIVERSITY PUTRA MALAYSIA   (Malaysia)

^b UNIVERSITY OF MALAYA   (Malaysia)

^c NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOLYSIN; PHOSPHOLIPASE;

ANIMAL; ARTICLE; CANDIDA; CANDIDIASIS; DRUG EFFECT; EGG YOLK; ENZYMOLOGY; ERYTHROCYTE; HOSPITAL; HUMAN; ISOLATION AND PURIFICATION; MALAYSIA; MICROBIOLOGY; SHEEP;

ANIMALS; CANDIDA; CANDIDIASIS; EGG YOLK; ERYTHROCYTES; HEMOLYSIN PROTEINS; HOSPITALS; HUMANS; MALAYSIA; PHOSPHOLIPASES; SHEEP;

EID: 84891456306     PISSN: 01275720     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Borst, A. & Fluit, A.C. (2003). High levels of hydrolytic enzymes secreted by Candida albicans isolates involved in respiratory infections. Journal of Medical Microbiology 52: 971-974.
2. Cutler, J.E. (1991). Putative virulence factors of Candida albicans. Annual Review of Microbiology 45: 187-218.
3. Dan, M., Poch, F. & Levin, D. (2002). High rate of vaginal infection caused by non-C. albicans Candida species among asymptomatic women. Medical Mycology 40: 383-386.
4. Hall, R.A., Cottier, F. & Mühlschlegel, F.A. (2009). Molecular networks in the fungal pathogen Candida albicans. Advances in Applied Microbiology 67: 191-212. I. ncI.
5. Inci M., Atalay, M.A., Koc, A.N., Yula, E., Evirgen, Ö., Durmaz, S. & Demir, G. (2012). Investigating the virulence factors of clinical Candida Isolates in relation to atmospheric conditions and genotypes. Turkish Journal of Medical Sciences 42(Sup2): 1476-1483.
6. 24(25)-sterol methyltransferase inhibitors in Candida spp. isolates, including non-albicans organisms. BMC Microbiology 9: 74.
7. Leroy, O., Gangneux, J.P., Montravers, P., Mira, J.P., Gouin, F., Sollet, J.P., Carlet, J., Reynes, J., Rosenheim, M., Regnier, B. & Lortholary, O., AmarCand Study Group (2009). Epidemiology, management, and risk factors for death of invasive Candida infections in critical care: a multicenter, prospective, observational study in France (2005-2006). Critical Care Medicine 37: 1612-1618.
8. Luo, G., Samaranayake, L.P. & Yau, J.Y.Y. (2001). Candida species exhibit differential in vitro hemolytic activities. Journal of Clinical Microbiology 39: 2971-2974.
9. Manns, J.M., Mosser, D.M. & Buckley, H.R. (1994). Production of hemolytic factor by Candida albicans. Infection and Immunity 62: 5154-5156.
10. Oksuz, S., Sahin, I., Yildirim, M., Gulcan, A., Yavuz, T., Kaya, D. & Koc, A.N. (2007). Phospholipase and proteinase activities in different Candida species isolated from anatomically distinct sites of healthy adults. Japanese Journal of Infectious Disease 60: 280-283.
11. Pfaller, M.A. & Diekema, D.J. (2007). Epidemiology of invasive candidiasis: a persistent public health problem. Clinical Microbiology Reviews 20: 133-167.
12. Pinto, E., Ribeiro, I.C., Ferreira, N.J., Fortes, C.E., Fonseca, P.A. & Figueiral, M.H. (2008). Correlation between enzyme production, germ tube formation and susceptibilitiy to fluconazole in Candida species isolated from patients with denture-related stomatitis and control individuals. Journal of Oral Pathology and Medicine 37: 587-592.
13. Price, M.F., Wilkinson, I.D. & Gentry, L.O. (1982). Plate method for detection of phospholipase activity in Candida albicans. Sabouraudia 20: 7-14.
14. Sachin, C.D., Ruchi, K. & Santosh, S. (2012). In vitro evaluation of proteinase, phospholipase and haemolysin activities of Candida species isolated from clinical specimens. International Journal of Medical and Biomedical Reserach 1: 153-157.
15. Samaranayake, L.P., Raeside, J.M. & MacFarlane, T.W. (1984). Factors affecting the phospholipase activity of Candida species in vitro. Sabouraudia 22: 201-207.
16. Schaller, M., Borelli, C., Korting, H.C. & Hube, B. (2005). Hydrolytic enzymes as virulence factors of Candida albicans. Mycoses 48: 365-377.
17. Tsang, C.S.P., Chu, F.C.S., Leung, W.K., Jin, L.J., Samaranayake, L.P. & Siu, S.C. (2007). Phospholipase, proteinase and haemolytic activities of Candida albicans isolated from oral cavities of patients with type 2 diabetes mellitus. Journal of Medical Microbiology 56: 1393-1398.
18. Yenişehirli, G., Bulut, Y. & Tuncoglu, E. (2010). Phospholipase, proteinase and hemolytic activities of Candida albicans isolates obtained from clinical specimens. Bulletin of Microbiology 44: 71-77.
19. Yigit. N. & Aktas, E. (2009). Comparison of the efficacy of different blood medium in determining the hemolytic activity of Candida species. Journal of Medical Mycology 19: 110-115.
20. Yigit, N., Aktas, E., Dagistan, S. & Ayyildiz, A. (2011). Investigating biofilm production, coagulase and haemolytic activity in Candida species isolated from denture stomatitis patients. The Eurasian Journal of Medicine 43: 27-32.